Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
home:starting:therapeutic_probe [08.06.2017] – [Therapeutic probe] removed mention of Mino from 2nd response re activation of innate immunity sallieqhome:starting:therapeutic_probe [09.14.2022] (current) – external edit 127.0.0.1
Line 7: Line 7:
 In the context of the therapeutic probe, there are at least three responses or types of responses which indicate that continued treatment with the MP is warranted: In the context of the therapeutic probe, there are at least three responses or types of responses which indicate that continued treatment with the MP is warranted:
   * **photosensitivity** – Even if patients have never been light sensitive before, they may find lights to be too bright for comfort.  Patients are cautioned that photosensitivity (and other symptoms) can occur in response to a [[home:lifestyle:light:photosensitivity#withdrawal|withdrawal]] of typical levels of light exposure, even before the use of olmesartan is commenced.   * **photosensitivity** – Even if patients have never been light sensitive before, they may find lights to be too bright for comfort.  Patients are cautioned that photosensitivity (and other symptoms) can occur in response to a [[home:lifestyle:light:photosensitivity#withdrawal|withdrawal]] of typical levels of light exposure, even before the use of olmesartan is commenced.
-  * **noticeable spike in symptoms** – Replacing 'vitamin' D in the VDR, Benicar ensures reactivation of the innate immune response, allowing destruction of pathogenic bacteria. The effect of a strengthened immune system response is called immunopathology. Immunopathology feels bad because the killing of bacteria generates cytokines, endotoxins, and nitric oxide. +  * **noticeable spike in symptoms** – Replacing 'vitamin' D in the VDR, Benicar ensures reactivation of the innate immune response, allowing destruction of pathogenic bacteria and viruses. The effect of a strengthened immune system response is called immunopathology. Immunopathology feels bad because the killing of bacteria generates cytokines, endotoxins, and nitric oxide. 
   * **noticeable relief in symptoms** – As an ARB, Benicar has profound anti-inflammatory effects, which manifest in a reduction in pain, fatigue, and other symptoms of Th1 disease.   * **noticeable relief in symptoms** – As an ARB, Benicar has profound anti-inflammatory effects, which manifest in a reduction in pain, fatigue, and other symptoms of Th1 disease.
  
Line 80: Line 80:
 {{tag>Starting_the_Marshall_Protocol}} {{tag>Starting_the_Marshall_Protocol}}
  
 +<nodisp>
 ===== Notes and comments ===== ===== Notes and comments =====
  
Line 86: Line 87:
 " Replacing 'vitamin' D in the VDR, Benicar ensures reactivation of the innate immune response, allowing destruction of pathogenic bacteria." " Replacing 'vitamin' D in the VDR, Benicar ensures reactivation of the innate immune response, allowing destruction of pathogenic bacteria."
   * Legacy content   * Legacy content
-    * http://www.marshallprotocol.com/forum32/1419.html f341  +    * https://www.marshallprotocol.com/forum32/1419.html f341  
-    * http://www.marshallprotocol.com/forum2/238.html#p23729 e136+    * https://www.marshallprotocol.com/forum2/238.html#p23729 e136
      
 * **Instructions**: wd surely need to be closer to Phase 1 guidelines, esp. that Benicar shd come //before// mino, shd be taken alone for a wk or more, & that each dose of mino shd be taken for at least a week. However, this makes the probe longer than 2 wks. Does a probe need to get up to 100mg mino?  * **Instructions**: wd surely need to be closer to Phase 1 guidelines, esp. that Benicar shd come //before// mino, shd be taken alone for a wk or more, & that each dose of mino shd be taken for at least a week. However, this makes the probe longer than 2 wks. Does a probe need to get up to 100mg mino? 
Line 95: Line 96:
  
   * Legacy content   * Legacy content
-    * http://www.marshallprotocol.com/view_topic.php?id=1080&forum_id=32&jump_to=46837#p46837 f2  +    * https://www.marshallprotocol.com/view_topic.php?id=1080&forum_id=32&jump_to=46837#p46837 f2  
-    * http://www.marshallprotocol.com/forum32/4703.html#p42913 f277  +    * https://www.marshallprotocol.com/forum32/4703.html#p42913 f277  
-    * http://www.marshallprotocol.com/forum37/3077.html s349  +    * https://www.marshallprotocol.com/forum37/3077.html s349  
-    * http://www.marshallprotocol.com/forum32/2177.html f325  +    * https://www.marshallprotocol.com/forum32/2177.html f325  
-    * http://www.marshallprotocol.com/forum32/1734.html f336  +    * https://www.marshallprotocol.com/forum32/1734.html f336  
-    * http://www.marshallprotocol.com/forum32/3948.html f308  +    * https://www.marshallprotocol.com/forum32/3948.html f308  
-    * http://www.marshallprotocol.com/view_topic.php?id=4304&forum_id=37&jump_to=88430#p88430 s81+    * https://www.marshallprotocol.com/view_topic.php?id=4304&forum_id=37&jump_to=88430#p88430 s81</nodisp> 
home/starting/therapeutic_probe.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.